Hence whenever early adaptation interventions (e.g., exercise intervention) after MI are impossible, due to aging or severe HF, therapeutic approaches targeting the miR-16-5p-SESN1 axis may be ideal alternatives, in the future. The gene discussed is SESN1; the disease is hydrops fetalis.